These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4571361)

  • 1. A phenothiazine in spasticity.
    Practitioner; 1973 Mar; 210(257):429-31. PubMed ID: 4571361
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative trial of dimethothiazine in spastic conditions.
    Practitioner; 1974 Jul; 213(1273):101-5. PubMed ID: 4614252
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of dantrolene sodium and diazepam in the treatment of spasticity.
    Glass A; Hannah A
    Paraplegia; 1974 Nov; 12(3):170-4. PubMed ID: 4616209
    [No Abstract]   [Full Text] [Related]  

  • 4. [Selective posterior rhizotomy in the treatment of spasticity].
    Sindou M; Fischer G; Goutelle A; Schott B; Mansuy L
    Rev Neurol (Paris); 1974; 130(5-6):201-16. PubMed ID: 4432013
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
    Smolenski C; Muff S; Smolenski-Kautz S
    Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term treatment of spasticity with tisanidine (sirdulad) in 2 cases of multiple sclerosis].
    Cendrowski W
    Wiad Lek; 1987 Dec; 40(24):1711-4. PubMed ID: 3451608
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of international clinical trials with Lioresal.
    Pinto Ode S; Polikar M; Debono G
    Postgrad Med J; 1972 Oct; 48():Suppl 5:18-25. PubMed ID: 4585726
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of spasticity with dantrolene sodium].
    Winnem M
    Tidsskr Nor Laegeforen; 1980 Oct; 100(29):1727-8. PubMed ID: 7008246
    [No Abstract]   [Full Text] [Related]  

  • 9. Ketazolam treatment for spasticity: double-blind study of a new drug.
    Basmajian JV; Shankardass K; Russell D; Yucel V
    Arch Phys Med Rehabil; 1984 Nov; 65(11):698-701. PubMed ID: 6149738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)].
    Gonsette RE; Capart T; Demonty L
    Acta Neurol Belg; 1978; 78(3):141-7. PubMed ID: 352084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of spasticity in neurological disease by dantrolen-sodium (author's transl)].
    Chantraine A; van Ouwenaller C
    Nervenarzt; 1980 Jan; 51(1):50-4. PubMed ID: 7393365
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional effects of spinal baclofen.
    Müller H
    Przegl Lek; 2007; 64 Suppl 2():1-2. PubMed ID: 17953269
    [No Abstract]   [Full Text] [Related]  

  • 13. [Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity].
    Ladd HW; Gingras G; Boucher J; Kazdan N; Keenan R
    Union Med Can; 1973 May; 102(5):1087-92. PubMed ID: 4576244
    [No Abstract]   [Full Text] [Related]  

  • 14. Levetiracetam for phasic spasticity in multiple sclerosis.
    Hawker K; Frohman E; Racke M
    Arch Neurol; 2003 Dec; 60(12):1772-4. PubMed ID: 14676055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.
    Groves L; Shellenberger MK; Davis CS
    Adv Ther; 1998; 15(4):241-51. PubMed ID: 10186943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of lioresal in therapy of spastic paralysis].
    Huffmann G; Fasshauer K; Giesen R
    Med Klin; 1973 Mar; 68(11):340-4. PubMed ID: 4691982
    [No Abstract]   [Full Text] [Related]  

  • 17. Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in Spain: the '5E' study.
    Arroyo R; Vila C; Clissold S
    Expert Rev Pharmacoecon Outcomes Res; 2011 Apr; 11(2):205-13. PubMed ID: 21476822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spasticity and the effect of dantrolene sodium.
    Monster AW
    Arch Phys Med Rehabil; 1974 Aug; 55(8):373-83. PubMed ID: 4605132
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
    Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial of baclofen against placebo.
    Hudgson P; Weightman D; Cartlidge NE
    Postgrad Med J; 1972 Oct; 48():Suppl 5:37-40. PubMed ID: 4585729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.